LG Life Science LTD. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

LG Life Science LTD. - Product Pipeline Review - 2016

LG Life Science LTD. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
LG Life Science LTD. - Product Pipeline Review - 2016
Published Sep 30, 2016
71 pages — Published Sep 30, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, LG Life Science LTD. - Product Pipeline Review - 2016, provides an overview of the LG Life Science LTD.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by LG Life Science LTD., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of LG Life Science LTD.
- The report provides overview of LG Life Science LTD. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses LG Life Science LTD.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features LG Life Science LTD.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate LG Life Science LTD.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for LG Life Science LTD.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding LG Life Science LTD.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08143CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables61
  List of Figures61
LG Life Science LTD. Snapshot71
  LG Life Science LTD. Overview71
  Key Facts71
LG Life Science LTD. Research and Development Overview84
  Key Therapeutic Areas84
LG Life Science LTD. Pipeline Review127
  Pipeline Products by Stage of Development121
  Pipeline Products Monotherapy131
  Pipeline Products Combination Treatment Modalities141
  Pipeline Products Partnered Products151
    Partnered Products/Combination Treatment Modalities161
  Pipeline Products Out-Licensed Products171
    Out-Licensed Products/Combination Treatment Modalities181
LG Life Science LTD. Pipeline Products Glance197
  LG Life Science LTD. Late Stage Pipeline Products191
    Pre-Registration Products/Combination Treatment Modalities191
    Phase III Products/Combination Treatment Modalities201
  LG Life Science LTD. Clinical Stage Pipeline Products211
    Phase II Products/Combination Treatment Modalities211
    Phase I Products/Combination Treatment Modalities221
  LG Life Science LTD. Early Stage Pipeline Products231
    Preclinical Products/Combination Treatment Modalities231
    Discovery Products/Combination Treatment Modalities241
  LG Life Science LTD. - Unknown Stage Pipeline Products251
    Unknown Products/Combination Treatment Modalities251
LG Life Science LTD. Drug Profiles2633
  (gemigliptin + glimepiride) Drug Profile261
  (gemigliptin + metformin hydrochloride) Drug Profile271
  (gemigliptin + rosuvastatin calcium) Drug Profile281
  (lercanidipine hydrochloride + valsartan) Drug Profile291
  adalimumab biosimilar Drug Profile301
  etanercept biosimilar Drug Profile311
  Eupenta Drug Profile321
  exenatide SR Drug Profile331
  infliximab biosimilar Drug Profile341
  interferon alfa-2a SR Drug Profile351
  LBDE Drug Profile361
  LBVC Drug Profile371
  LBVD Drug Profile381
  LBVE-013 Drug Profile391
  LBVE-014 Drug Profile401
  LC-231306 Drug Profile411
  LC-280126 Drug Profile421
  LC-280391 Drug Profile431
  LC-34AD3 Drug Profile441
  LC-350189 Drug Profile451
  LC-541239 Drug Profile461
  LC-65AOD3 Drug Profile471
  LD-02GIFRO Drug Profile481
  Monoclonal Antibody to Inhibit VEGF for Cancer Drug Profile491
  NecX Drug Profile501
  nivocasan Drug Profile511
  rituximab biosimilar Drug Profile521
  Small Molecule to Inhibit PAR-1 for Atherothrombosis Drug Profile531
  Small Molecules for Obesity Drug Profile541
  Small Molecules to Inhibit 20S Proteasome for Multiple Myeloma and Solid Tumor Drug Profile551
  somatropin Drug Profile561
  somatropin SR Drug Profile572
LG Life Science LTD. Pipeline Analysis598
  LG Life Science LTD. Pipeline Products by Target593
  LG Life Science LTD. Pipeline Products by Route of Administration621
  LG Life Science LTD. Pipeline Products by Molecule Type631
  LG Life Science LTD. Pipeline Products by Mechanism of Action643
LG Life Science LTD. Dormant Projects671
LG Life Science LTD. Locations And Subsidiaries682
  Head Office681
  Other Locations &Subsidiaries682
Appendix702
  Methodology701
  Coverage701
  Secondary Research701
  Primary Research701
  Expert Panel Validation701
  Contact Us701
  Disclaimer711

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "LG Life Science LTD. - Product Pipeline Review - 2016" Sep 30, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/LG-Life-Science-LTD-Product-Pipeline-Review-2016-2088-16774>
  
APA:
Global Markets Direct - Market Research. (2016). LG Life Science LTD. - Product Pipeline Review - 2016 Sep 30, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/LG-Life-Science-LTD-Product-Pipeline-Review-2016-2088-16774>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.